Landos Biopharma Inc (LABP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2020 | 03-2020 | 12-2019 | |
| Operating Expenses | 5,088 | 5,770 | 0 |
| Operating Income | -5,088 | -5,770 | N/A |
| Interest Expense | 0 | 1 | 0 |
| Other Income | 311 | -25 | 0 |
| Pre-tax Income | -4,777 | -5,796 | 0 |
| Net Income Continuous | -4,777 | -5,796 | N/A |
| Net Income | $-4,777 | $-5,796 | $N/A |
| EPS Basic Total Ops | -7.30 | -4.90 | N/A |
| EPS Basic Continuous Ops | -3.96 | -4.88 | N/A |
| EPS Diluted Total Ops | -7.30 | -4.90 | N/A |
| EPS Diluted Continuous Ops | -3.96 | -4.88 | N/A |
| EBITDA(a) | $-5,014 | $-5,705 | $N/A |